Supply and Clinical Application of Actinium-225 and Bismuth-213

por Morgenstern, Alfred, Apostolidis, Christos, Bruchertseifer, Frank
Publicado 2020

Radium and Francium beam tests to produce 225Ac/ 213Bi generators at CERN-MEDICIS

por Bruchertseifer, Frank, Morgenstern, Alfred, Martinez, Yisel, Cocolios, Thomas, Stora, Thierry
Publicado 2015

Functionalized NaA nanozeolites labeled with (224,225)Ra for targeted alpha therapy

por Piotrowska, Agata, Leszczuk, Edyta, Bruchertseifer, Frank, Morgenstern, Alfred, Bilewicz, Aleksander
Publicado 2013

Targeted alpha therapy for glioblastoma

por Kunikowska, Jolanta, Morgenstern, Alfred, Pełka, Kacper, Bruchertseifer, Frank, Królicki, Leszek
Publicado 2022

An Overview of Targeted Alpha Therapy with (225)Actinium and (213)Bismuth

por Morgenstern, Alfred, Apostolidis, Christos, Kratochwil, Clemens, Sathekge, Mike, Krolicki, Leszek, Bruchertseifer, Frank
Publicado 2018

Global experience with PSMA-based alpha therapy in prostate cancer

por Sathekge, Mike M., Bruchertseifer, Frank, Vorster, Mariza, Morgenstern, Alfred, Lawal, Ismaheel O.
Publicado 2021

Assessment of (213)Bi-anti-EGFR MAb treatment efficacy in malignant cancer cells with [1-(13)C]pyruvate and [(18)F]FDG

por Feuerecker, Benedikt, Michalik, Michael, Hundshammer, Christian, Schwaiger, Markus, Bruchertseifer, Frank, Morgenstern, Alfred, Seidl, Christof
Publicado 2019

First‐Generation Bispidine Chelators for (213)Bi(III) Radiopharmaceutical Applications

por Bruchertseifer, Frank, Comba, Peter, Martin, Bodo, Morgenstern, Alfred, Notni, Johannes, Starke, Miriam, Wadepohl, Hubert
Publicado 2020

Diverse metabolic response of cancer cells treated with a (213)Bi-anti-EGFR-immunoconjugate

por Feuerecker, Benedikt, Biechl, Philipp, Seidl, Christof, Bruchertseifer, Frank, Morgenstern, Alfred, Schwaiger, Markus, Eisenreich, Wolfgang
Publicado 2021

α-Zirconium(IV) Phosphate: Static Study of (225)Ac Sorption in an Acidic Environment and Its Kinetic Sorption Study Using (nat)Eu as a Model System for (225)Ac

por Ondrák, Lukáš, Ondrák Fialová, Kateřina, Vlk, Martin, Štamberg, Karel, Bruchertseifer, Frank, Morgenstern, Alfred, Kozempel, Ján
Publicado 2023

Dual‐Nuclide Radiopharmaceuticals for Positron Emission Tomography Based Dosimetry in Radiotherapy

por Wurzer, Alexander, Seidl, Christof, Morgenstern, Alfred, Bruchertseifer, Frank, Schwaiger, Markus, Wester, Hans‐Jürgen, Notni, Johannes
Publicado 2017

Efficient formation of inert Bi-213 chelates by tetraphosphorus acid analogues of DOTA: towards improved alpha-therapeutics

por Šimeček, Jakub, Hermann, Petr, Seidl, Christof, Bruchertseifer, Frank, Morgenstern, Alfred, Wester, Hans-Jürgen, Notni, Johannes
Publicado 2018

Alpha-Particle Emitting (213)Bi-Anti-EGFR Immunoconjugates Eradicate Tumor Cells Independent of Oxygenation

por Wulbrand, Christian, Seidl, Christof, Gaertner, Florian C., Bruchertseifer, Frank, Morgenstern, Alfred, Essler, Markus, Senekowitsch-Schmidtke, Reingard
Publicado 2013

Functionalized TiO(2) nanoparticles labelled with (225)Ac for targeted alpha radionuclide therapy

por Cędrowska, Edyta, Pruszynski, Marek, Majkowska-Pilip, Agnieszka, Męczyńska-Wielgosz, Sylwia, Bruchertseifer, Frank, Morgenstern, Alfred, Bilewicz, Aleksander
Publicado 2018

In Vitro comparison of (213)Bi- and (177)Lu-radiation for peptide receptor radionuclide therapy

por Chan, Ho Sze, de Blois, Erik, Morgenstern, Alfred, Bruchertseifer, Frank, de Jong, Marion, Breeman, Wouter, Konijnenberg, Mark
Publicado 2017

Targeted alpha therapy of mCRPC: Dosimetry estimate of (213)Bismuth-PSMA-617

por Kratochwil, Clemens, Schmidt, Karl, Afshar-Oromieh, Ali, Bruchertseifer, Frank, Rathke, Hendrik, Morgenstern, Alfred, Haberkorn, Uwe, Giesel, Frederik L.
Publicado 2017

Dose escalation study of targeted alpha therapy with [(225)Ac]Ac-DOTA-substance P in recurrence glioblastoma – safety and efficacy

por Królicki, Leszek, Bruchertseifer, Frank, Kunikowska, Jolanta, Koziara, Henryk, Pawlak, Dariusz, Kuliński, Radosław, Rola, Rafał, Merlo, Adrian, Morgenstern, Alfred
Publicado 2021

Long-Term Tumor Control Following Targeted Alpha Therapy (TAT) of Low-Grade Gliomas (LGGs): A New Treatment Paradigm?

por Krolicki, Leszek, Kunikowska, Jolanta, Cordier, Dominik, Slavova, Nedelina, Koziara, Henryk, Bruchertseifer, Frank, Maecke, Helmut R., Morgenstern, Alfred, Merlo, Adrian
Publicado 2023

Trastuzumab Modified Barium Ferrite Magnetic Nanoparticles Labeled with Radium-223: A New Potential Radiobioconjugate for Alpha Radioimmunotherapy

por Gawęda, Weronika, Pruszyński, Marek, Cędrowska, Edyta, Rodak, Magdalena, Majkowska-Pilip, Agnieszka, Gaweł, Damian, Bruchertseifer, Frank, Morgenstern, Alfred, Bilewicz, Aleksander
Publicado 2020

Pharmacokinetics, microscale distribution, and dosimetry of alpha-emitter-labeled anti-PD-L1 antibodies in an immune competent transgenic breast cancer model

por Nedrow, Jessie R., Josefsson, Anders, Park, Sunju, Bäck, Tom, Hobbs, Robert F., Brayton, Cory, Bruchertseifer, Frank, Morgenstern, Alfred, Sgouros, George
Publicado 2017